Concepedia

Margaret E. Duncan

ME

Statistics

Publications

14

Citations

1.5K

H-Index

14

Active since

1970

Affiliations

Institute of Cancer Research(Current)

University of Aberdeen

Vertex Pharmaceuticals (United States)

Charité - Universitätsmedizin Berlin

Margaret E. Duncan is an author at Institute of Cancer Research specializing in medicine, tumor biology, and pathology.

Top concepts

Publications per year

1970–2023

14

Publications

14

Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer

Graeme I. Murray, Margaret E. Duncan, Pauline O'Neil et al. · Nature Medicine · 1996 · 446 citations

, , +5

Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer

Graeme I. Murray, Margaret E. Duncan, Pauline O'Neil et al. · Nature Medicine · 1996 · 323 citations

, , +5

Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

Graeme I. Murray, Margaret E. Duncan, Pauline O'Neil et al. · The Journal of Pathology · 1998 · 285 citations

The induction of azaguanine-resistant mutants in cultured Chinese hamster cells by reactive derivatives of carcinogenic hydrocarbons.

Margaret E. Duncan, P. Brookes · PubMed · 1973 · 77 citations

The induction of azaguanine-resistant mutants in cultured Chinese hamster cells by reactive derivatives of carcinogenic hydrocarbons

Margaret E. Duncan, P. Brookes · Mutation Research/Environmental Mutagenesis and Related Subjects · 1973 · 66 citations

, , +8

1–5 of 14